Doo-Man Oh
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 4
-
- Protein Interaction Studies and Fluorescence Analysis 1
- Co-authors
- Tomi Järvinen (1 shared paper)Reza Oliyai (1 shared paper)Jouko Savolainen (1 shared paper)Jarkko Rautio (1 shared paper)Hanna Kumpulainen (1 shared paper)Tycho Heimbach (1 shared paper)Adriaan Cleton (1 shared paper)Kjell Johnson (1 shared paper)
- Journals
- Archives of Pharmacal Research (1 paper)Journal of Pharmaceutical Investigation (1 paper)Journal of Pharmaceutical Sciences (1 paper)International Journal of Pharmaceutics (1 paper)Nature Reviews Drug Discovery (1 paper)
- Partner nations
- United StatesFinlandSouth Korea
In The Last Decade
Doo-Man Oh
6 papers receiving 1.3k citations
Doo-Man Oh's Hit Papers
Peers
Comparison fields: 5 of 105
- Pharmaceutical Science 164
- Biomaterials 197
- Pharmacology 99
- Organic Chemistry 279
- Molecular Biology 571
Countries citing papers authored by Doo-Man Oh
This map shows the geographic impact of Doo-Man Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doo-Man Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doo-Man Oh more than expected).
Fields of papers citing papers by Doo-Man Oh
This network shows the impact of papers produced by Doo-Man Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doo-Man Oh. The network helps show where Doo-Man Oh may publish in the future.
Co-authors
The 16 scholars most cited alongside Doo-Man Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prodrugs: design and clinical applications Hit paper breakdown → | 2008 | 1256 |
| 2 | 2003 | 41 | |
| 3 | 1993 | 15 | |
| 4 | Estimating oral drug absorption in humans. | 1991 | 4 |
| 5 | Uptake of a Dipeptide by the Dipeptide Transporter in the HT-29 Intestinal Cells | 1995 | 1 |
| 6 | 1995 | 1 |
About Doo-Man Oh
Doo-Man Oh is a scholar working on Oncology, Molecular Biology, Biochemistry, Infectious Diseases and Organic Chemistry, having authored 6 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Amino Acid Enzymes and Metabolism (2 papers), HIV/AIDS drug development and treatment (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Computational Drug Discovery Methods (1 paper), Click Chemistry and Applications (1 paper), Protein Interaction Studies and Fluorescence Analysis (1 paper) and Gastroesophageal reflux and treatments (1 paper). The work is most often cited by research in Pharmaceutical Science (164 citations), Biomaterials (197 citations), Pharmacology (99 citations), Organic Chemistry (279 citations) and Molecular Biology (571 citations). Doo-Man Oh has collaborated with scholars based in United States, Finland and South Korea. Frequent co-authors include Tomi Järvinen, Reza Oliyai, Jouko Savolainen, Jarkko Rautio, Hanna Kumpulainen, Tycho Heimbach, Adriaan Cleton, Kjell Johnson, Patrick J. Sinko and Chad Stoner. Their work appears in journals such as Archives of Pharmacal Research, Journal of Pharmaceutical Investigation, Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.